CAPTRUST Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $247M | Sell |
1,771,496
-164,642
| -9% | -$23.1M | 0.43% | 41 |
|
|
2025
Q4 | $238M | Buy |
1,936,138
+28,012
| +1% | +$3.4M | 0.45% | 41 |
|
|
2025
Q3 | $212M | Buy |
1,908,126
+29,500
| +2% | +$3.35M | 0.43% | 41 |
|
|
2025
Q2 | $208M | Buy |
1,878,626
+51,571
| +3% | +$5.49M | 0.46% | 39 |
|
|
2025
Q1 | $205M | Buy |
1,827,055
+50,085
| +3% | +$5.17M | 0.51% | 37 |
|
|
2024
Q4 | $164M | Buy |
1,776,970
+96,271
| +6% | +$8.67M | 0.47% | 41 |
|
|
2024
Q3 | $141M | Buy |
1,680,699
+49,776
| +3% | +$3.8M | 0.42% | 46 |
|
|
2024
Q2 | $112M | Sell |
1,630,923
-14,355
| -0.9% | -$958K | 0.36% | 57 |
|
|
2024
Q1 | $109M | Buy |
1,645,278
+154,217
| +10% | +$11.9M | 0.4% | 51 |
|
|
2023
Q4 | $121M | Buy |
1,491,061
+28,861
| +2% | +$2.25M | 0.42% | 47 |
|
|
2023
Q3 | $110M | Buy |
1,462,200
+24,809
| +2% | +$1.91M | 0.42% | 48 |
|
|
2023
Q2 | $111M | Buy |
1,437,391
+30,854
| +2% | +$2.46M | 0.44% | 47 |
|
|
2023
Q1 | $117M | Buy |
1,406,537
+65,042
| +5% | +$5.39M | 0.51% | 40 |
|
|
2022
Q4 | $115M | Sell |
1,341,495
-66,157
| -5% | -$5.24M | 0.58% | 36 |
|
|
2022
Q3 | $86.8M | Buy |
1,407,652
+128,656
| +10% | +$8.11M | 0.51% | 39 |
|
|
2022
Q2 | $79.1M | Buy |
1,278,996
+162,535
| +15% | +$10.1M | 0.51% | 40 |
|
|
2022
Q1 | $66.4M | Buy |
1,116,461
+128,748
| +13% | +$8.23M | 0.43% | 52 |
|
|
2021
Q4 | $71.7M | Buy |
987,713
+44,649
| +5% | +$3.08M | 0.49% | 41 |
|
|
2021
Q3 | $65.9M | Buy |
943,064
+83,250
| +10% | +$5.85M | 0.55% | 40 |
|
|
2021
Q2 | $59.2M | Buy |
859,814
+76,532
| +10% | +$5.11M | 0.55% | 39 |
|
|
2021
Q1 | $50.6M | Buy |
783,282
+65,609
| +9% | +$4.23M | 0.55% | 39 |
|
|
2020
Q4 | $41.8M | Buy |
717,673
+442,550
| +161% | +$26.7M | 0.55% | 30 |
|
|
2020
Q3 | $17.4M | Buy |
275,123
+242,957
| +755% | +$16.8M | 0.29% | 94 |
|
|
2020
Q2 | $2.45M | Buy |
32,166
+581
| +2% | +$44.5K | 0.04% | 315 |
|
|
2020
Q1 | $2.29M | Sell |
31,585
-6,670
| -17% | -$461K | 0.05% | 287 |
|
|
2019
Q4 | $2.5M | Buy |
38,255
+26,805
| +234% | +$1.75M | 0.04% | 336 |
|
|
2019
Q3 | $726K | Sell |
11,450
-302
| -3% | -$19.7K | 0.03% | 352 |
|
|
2019
Q2 | $794K | Buy |
11,752
+1,307
| +13% | +$86K | 0.03% | 323 |
|
|
2019
Q1 | $679K | Buy |
10,445
+2,170
| +26% | +$144K | 0.03% | 318 |
|
|
2018
Q4 | $518K | Sell |
8,275
-2,816
| -25% | -$197K | 0.03% | 306 |
|
|
2018
Q3 | $856K | Buy |
11,091
+2,400
| +28% | +$181K | 0.04% | 240 |
|
|
2018
Q2 | $616K | Sell |
8,691
-586
| -6% | -$41.4K | 0.03% | 230 |
|
|
2018
Q1 | $679K | Buy |
9,277
+2,207
| +31% | +$175K | 0.04% | 203 |
|
|
2017
Q4 | $506K | Buy |
7,070
+845
| +14% | +$64.2K | 0.03% | 230 |
|
|
2017
Q3 | $503K | Buy |
+6,225
| New | +$476K | 0.04% | 162 |
|
Other funds holding GILD
VCM
VPM
CAPTRUST Financial Advisors's GILD Position: Q1 2026 in Review
CAPTRUST Financial Advisors reduced its Gilead Sciences (GILD) stake by 8.5% in Q1 2026, selling an estimated $23.1M and leaving 1,771,496 shares worth $247M. The position accounts for 0.43% of the portfolio, ranked #41.
CAPTRUST Financial Advisors first reported a position in GILD in Q3 2017 and has held it in 35 quarters since. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- CAPTRUST Financial Advisors held 1,771,496 shares of Gilead Sciences worth $247M as of Q1 2026.
- CAPTRUST Financial Advisors sold 164,642 Gilead Sciences shares in Q1 2026, an estimated $23.1M.
- Gilead Sciences made up 0.43% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #41 holding.
- CAPTRUST Financial Advisors first reported a position in Gilead Sciences in Q3 2017 and has held it in 35 quarters since.
- 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.